Hosted on MSN1mon
Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform
The initiation comes with a positive outlook on the company's potential in the field of precision medicine, particularly highlighting their next-generation platform, AP3, and its application in ...
Yahoo Finance18d
Air Products & Chemicals Inc (AP3.HA)
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
manilatimes1mon
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer
Feb. 05, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon Predictive ...